DUBLIN, June 8, 2022 /PRNewswire/ — The 3D Cell Cultures Market by Scaffold Format, Products, Application Areas, Purpose and Key Geographic Regions: Industry Trends and Global Forecasts, 2022-2035 report has been added ResearchAndMarkets.com Offer.
The 3D Cell Culture Market report provides a comprehensive study of the current landscape and offers an informed opinion on the likely medium to long-term evolution of the market. The study also includes an in-depth analysis highlighting the capabilities of various industry players operating in this space.
Currently, more than 140 companies offer 3D cell culture systems in a variety of formats, including scaffold-based products, scaffold-free products, and 3D bioreactors.
These systems have been shown to be able to more accurately simulate the natural tissue microenvironment, enhanced cell-to-cell and cell-to-ECM interactions, more accurate assessment of drug toxicity and cellular responses, and co-cultivation to offer several cell types.
In addition, there are certain complex 3D cell culture models that can even replace animal models, which show reproducible results and thereby serve as better in vivo models in several application areas. Given the various advantages of such systems, the field has attracted the attention of various venture capital firms and strategic investors, who have provided financial support to advance research efforts focused on exploring various formats of 3D cell culture systems, including organoids and organ-on- Chips in multiple application areas.
In addition, the scientific literature on 3D cell culture systems and collaborations for 3D bioreactors and cell culture products has increased. Given the ongoing innovations in this field and the paradigm shift from 2D cell culture systems and animal experiments to 3D cell culture models, the market is expected to witness significant growth in the foreseeable future.
The report includes detailed transcripts of interviews conducted with the following industry and non-industry players:
-
Brigitte Agres (Co-founder, Cellendes)
-
Bill Anderson (President and CEO, Synthecon)
-
Anonymous (President and CEO, Anonymous)
-
Anonymous (Co-Founder and Vice President, Anonymous)
-
Scott Brush (Vice President, BRTI Life Sciences)
-
Malcolm Wilkinson (Managing Director, Kirkstall)
-
Ryder Clifford (Director, QGel) and Simon Carlo Rizzi (Chief Scientific Officer, QGel)
-
Tanya Yankelevich (Director, Xylyx Bio)
-
Jen Kelm (Chief Scientific Officer, InSphero)
-
Walter Tinganelli (Group leader, GSI)
-
Darlene Thieken (Project Manager, Nanofiber Solutions)
-
Andrea Picon (Director, Business Development, FlexCell International)
-
Frank Juncker (CEO, InSphero)
-
Mohammed Mamunur Rahman (Manager, Business Development, MBL International)
key questions answered
-
Who are the leading industry players involved in the development of 3D cell culture products?
-
What are the most popular 3D cell culture products?
-
For which different areas of application are 3D cell culture products being developed?
-
What are the key factors that are likely to influence the development of the 3D cell culture systems market?
-
What is the capital investment trend in 3D Cell Culture Systems market?
-
What partnership models are commonly adopted by stakeholders in the 3D cell culture market?
-
How are current and future opportunities likely to be distributed across key market segments?
-
What are the expected future trends related to the 3D Cell Culture Systems Market?
Main topics covered:
1 INTRODUCTION
2. SUMMARY
3. INTRODUCTION
3.1. Chapter overview
3.2. Types of Cell Cultures
3.3. Morphology of cells in culture
3.4. 2D cell cultures vs. 3D cell cultures
3.5. Overview of 3D cell culture
3.6. Establishment and maintenance of cell cultures
3.7. Requirements for maintaining healthy cell cultures
3.8. Applications of 3D cell culture systems
3.9. Advantages and limitations of 3D cell culture systems
3.10. future prospects
4. CLASSIFICATION OF 3D CELL CULTURE SYSTEMS
4.1. 3D cell culture classification
4.2. Scaffold-based 3D cell cultures
4.3. Scaffold-free 3D cell cultures
4.4. organoids
5. FABRICATION OF 3D MATRICES AND FRAMEWORKS
5.1. Chapter overview
5.2. Process for preparing porous scaffolds
5.3. Process for the production of fiber scaffolds
5.4. Method of making hydrogels
5.5. Methods for making custom scaffolding
5.6. Method of making microspheres
5.7. Procedure for preparing native scaffolds
6. 3D CELL CULTURE SYSTEMS: DEVELOPER LANDSCAPE
6.1. Chapter overview
6.2. Developers of 3D cell culture systems: overall market landscape
6.3. 3D Cell Cultures: List of Service Providers
6.4. 3D Cell Cultures: List of Associated Assays, Kits, and Reagents
7. MARKET LANDSCAPE: SCAFFOLDING BASED PRODUCTS
7.1. Chapter overview
7.2. Scaffold-based products: overall market landscape
7.3. Scaffolding-based products: developer landscape
8. MARKET LANDSCAPE: SCAFFOLDING FREE PRODUCTS
8.1. Chapter overview
8.2. Scaffold-free products: overall market landscape
8.3. Scaffold-free products: developer landscape
9. MARKET LANDSCAPE: 3D BIOREACTORS
9.1. Chapter overview
9.2. 3D bioreactors: overall market landscape
9.3. 3D bioreactors: developer landscape
10. MAJOR AREAS OF APPLICATION
10.1. Chapter overview
10.2. 3D cell culture systems in cancer research
10.3. 3D cell culture systems in drug discovery and toxicity screening
10.4. 3D cell culture systems in stem cell research
10.5. 3D cell cultures in regenerative medicine and tissue engineering
10.6. 3D Cell Culture Systems: Analysis by Main Areas of Application
11. COMPANY PROFILES: SCAFFOLD-BASED PRODUCTS (HYDROGEL/ECM DEVELOPER)
11.1. Chapter overview
11.1.1. 3D biotec
11.1.2. Advanced BioMatrix
11.1.3. alpha bioregen
11.1.4. Corning Life Sciences
11.1.5. REPROCESS
12. COMPANY PROFILES: FRAMEWORK FREE PRODUCTS (ORGAN ON CHIPS DEVELOPER)
12.1. Chapter overview
12.1.1. CN Bio Innovations
12.1.2. Emulate, emulate
12.1.3. InSphero
12.1.4. MIMETAS
12.1.5. TissUse
13. COMPANY PROFILES: 3D BIOREACTORS
13.1. Chapter overview
13.2. BISS TGT
13.3. Celartia
13.4. cell culture
13.5. BOAR
13.6. Flexcell International
13.7. PBS Biotech
13.8. synthecon
14. FUNDING AND INVESTMENT ANALYSIS
14.1. Chapter overview
14.2. Types of Funding
14.3. 3D Cell Culture Systems: Funding and Investment Analysis
14.4 Summary of Funding and Investments
15. PARTNERSHIPS AND COLLABORATION
15.1. Chapter overview
15.2. partnership models
15.3. 3D Cell Culture Systems: List of Partnerships and Collaborations
16. PATENT ANALYSIS
16.1. Chapter overview
16.2. scope and methodology
16.3. 3D Cell Culture Systems: Patent Analysis
16.4. 3D Cell Culture Systems: Patent Evaluation Analysis
16.5. Leading Patents: Analysis by Number of Citations
17. PUBLICATION ANALYSIS
17.1. 3D cell culture systems: publication analysis
17.2. Assumptions and key parameters
17.3. methodology
18. PRODUCT COMPETITIVENESS ANALYSIS
18.1. Chapter overview
18.2. Assumptions / Key Parameters
18.3. methodology
18.4. Product Competitive Analysis: 3D Bioreactors
19. CASE STUDY: ORGANIDS AND ORGAN-ON-CHIPS
19.1. Chapter overview
19.2. Organoids and Organ-on-Chips: Product List
19.3. Organoids and Organ-on-Chips: List of Product Developers
20. MARKET FORECAST
20.1. Chapter overview
20.2. Key assumptions and forecast methodology
20.3. Global 3D Cell Culture Market, 2022-2035
20.4. Global 3D Cell Culture Market: Distribution by Business Segments
20.5. Global 3D Cell Culture Systems Market: Distribution by 3D Cell Culture Format
20.6. Global 3D Cell Culture Systems Market: Distribution by Product Type
20.7. Global 3D Cell Culture Systems Market: Distribution by Application Areas
20.8. Global 3D Cell Culture Systems Market: Distribution by Purpose
20.9. Global 3D Cell Culture Systems Market: Distribution by Geography
21. SURVEY ANALYSIS
21.1. Chapter overview
21.2. Overview of the respondents
21.2.1. Naming the respondents
21.3. Survey Insights
21.3.1. 3D cell culture format
21.3.2. Type of products offered
21.3.3. Product development status
21.3.4. Source for 3D cultured cells
21.3.5. Process used to manufacture
21.3.6. areas of application
21.3.7. Range of services for 3D cell cultures
21.3.8. Current and future market opportunities
22. CONCLUSION
23. EXECUTIVE INSIGHTS
23.1. Chapter overview
23.2. cell ends
23.2.1. company snapshot
23.2.2. Interview protocol: Brigitte Agresco-founder
23.3. Synthecon
23.3.1. company snapshot
23.3.2. Interview protocol: Bill AndersonPresident and Chief Executive Officer
23.4. Anonymous
23.4.1. Interview Transcript: Anonymous, President and Chief Executive Officer
23.5. Anonymous
23.5.1. Interview Transcript: Anonymous, Co-Founder and Vice President
23.6. BRTI Life Sciences
23.6.1. company snapshot
22.6.2. Interview protocol: Scott BrushVice President
23.7. Kirkstall
23.7.1. company snapshot
23.7.2. Interview protocol: Malcolm Wilkinsonboard member
23.8. Qgel
23.8.1. company snapshot
23.8.2. Interview protocol: Ryder CliffordCEO and Simon Carlo RizziScientific Director
23.9. Xylyx Bio
23.9.1. company snapshot
23.9.2. Interview protocol: Tanya YankelevichFormer director of product management and business development
23.10. InSphero
23.10.1. company snapshot
23.10.2. Interview protocol: Jen Kelmformer Chief Scientific Officer
23.11. GSI
23.11.1. company snapshot
23.11.2. Interview protocol: Walter Tinganelli, group leader, clinical radiobiology
23.12. nanofiber solutions
23.12.1. company snapshot
23.12.2. Interview protocol: Darlene ThiekenFormer project manager
23.13. FlexCell International
23.13.1. company snapshot
23.13.2. Interview protocol: Andrea PiconHead of Business Development
23.14. InSphero
23.14.1. company snapshot
23.14.2. Interview protocol: Frank JunckerChief Business Officer
23.15. MBL International
23.15.1. company snapshot
23.15.2. Interview Transcript: Mamun, Rahman, Manager, Business Development
24. APPENDIX I: TABULED DATA
25. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For more information about this report, visit https://www.researchandmarkets.com/r/ytgwdi
Media contact:
research and markets
Laura WoodSenior managers
press@researchandmarkets.com
For EST office hours, call +1-917-300-0470
For USA/CAN, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900
US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716
View original content: https://www.prnewswire.com/news-releases/global-3d-cell-culture-market-research-report-2022-more-than-140-companies-offer-3d-cell-culture-systems -in-various-formats-301563910.html
SOURCE Research and Markets